About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Coaching for HCV and HIV | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT04314414

Coaching for HCV and HIV

The objective of this study is to determine the feasibility and acceptability of a peer recovery coach (PRC) intervention to improve linkage to hepatitis C (HCV) and/or human immunodeficiency virus (H...

Lead sponsor: Boston Medical Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Boston Medical Center

Collaborators

National Institute of Allergy and Infectious Diseases (NIAID)
Boston University

\*NOTE\* Due to the COVID-19 pandemic, surveys were conducted via telephone and not all participants could be contacted. Therefore, the number of results from participants at three months and six months vary. The data gathered are from participants that were reachable and completed the surveys.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Individuals with opioid use disorder, non-reactive HIV antibody test and reactive HCV antibody testing at the BMC LBA walk-in clinic
•Able to speak English
•Individuals providing contact information of two family members or friends
•Individuals signing a medical records release form

Exclusion Criteria

•Individuals already linked to substance use care
•Individuals co-infected with HIV and HCV and engaged in care

Related studies

SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant Families

NCT06627764 · Substance Abuse, Intimate Partner Violence (IPV), and more

Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)

NCT04197921 · Opioid-use Disorder, Substance Use Disorders

RECRUITINGPhase 3

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

NCT06694805 · HIV Infections

Skeletal Muscle Energetics and Fatiguability in Older Individuals

NCT04142047 · HIV, HIV Infections

Optimization of NIBS for Treatment of Addiction

NCT04379115 · Opioid-use Disorder, Chronic Pain

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 19, 2022Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment31

Start dateDec 2020

Last updatedDec 19, 2022

Condition

Hepatitis C HIV Infections Opioid-use Disorder

Locations shown

Boston Medical Center - Low-Barrier-Access (LBA) walk-in clinic

Boston, Massachusetts

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 19, 2022Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions